Meet us at the POLEPHARMA Microbiomics Days
GenoScreen will participate in the 1st edition of the POLEPHARMA Microbiomics Days which will be organized on April 9 & 10 at the HEALTH UFR of the University of Rouen.
World TB Day: GenoScreen participates to the International Tuberculosis Conference in Brussels!
On March 21st, Genoscreen will participate in the “International Conference on Tuberculosis” in Brussels.
GenoScreen finalizes a €1 million fundraising campaign to continue its international expansion
GenoScreen announced today that it has completed a €1 million fundraising campaign with private investors. Pioneer company since 2001 in sequencing, genotyping and bioinformatics, GenoScreen provides innovative services and solutions in genomics to address the needs of academic and industrial research teams. At the forefront of genomics in France, GenoScreen develops innovation programs that fuel […]
Meet us at BioFIT 2018!
On the 4th and 5th of December 2018, Genoscreen will participate at the 7th edition of the BioFIT business convention which will take place this year in Lille Grand Palais.
Metabiote® protocol is now GCLP compliant
Metabiote®, the reference protocol in targeted metagenomics developed by GenoScreen, is now GCLP compliant.
A major advance in the fight against multidrug-resistant tuberculosis
Deeplex®-MycTB, was used in a study published in The Lancet Infectious Diseases highlighting the spread of tuberculosis strains resistant to first-line antibiotics, not detected by current diagnostic tests.
Improving, through the genomic approach, the diagnosis, monitoring and follow-up of polluted sites: the conclusions of the BioDISSPOL project
GenoScreen will present the conclusions of the BioDISSPOL project on November 28 at Pollutec Lyon during the panel discussion: “Microbial Biomarkers : Application to the diagnosis and management of polluted sites”.
Discover Deeplex-MycTB
Discover Deeplex-MycTB, a next-generation molecular analysis solution that allows, in a single test, to identify the mycobacteria of the M. tuberculosis complex causing tuberculosis, to predict their resistance to multiple antibiotics of first and second intent and to type them for epidemiological surveillance purposes.
Molecular identification of microorganisms
Molecular identification of microorganisms, to strengthen health and food safety. More information on this page
The Deeplex-MycTB solution presented in Les Echos
Check out the Les Echos article on our innovative Deeplex-MycTB solution, a next-generation test for combating multidrug-resistant TB.